dox fluorescence Search Results


dox fluorescence  (CEM Corporation)
90
CEM Corporation dox fluorescence
Dox Fluorescence, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dox fluorescence/product/CEM Corporation
Average 90 stars, based on 1 article reviews
dox fluorescence - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
doxorubicin fluorescence (dox)  (CEM Corporation)
90
CEM Corporation doxorubicin fluorescence (dox)
Doxorubicin Fluorescence (Dox), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/doxorubicin fluorescence (dox)/product/CEM Corporation
Average 90 stars, based on 1 article reviews
doxorubicin fluorescence (dox) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
self-fluorescent dox-loaded hnps with unique aiegen characteristic  (AIEgen Biotech Co Ltd)
90
AIEgen Biotech Co Ltd self-fluorescent dox-loaded hnps with unique aiegen characteristic
Self Fluorescent Dox Loaded Hnps With Unique Aiegen Characteristic, supplied by AIEgen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/self-fluorescent dox-loaded hnps with unique aiegen characteristic/product/AIEgen Biotech Co Ltd
Average 90 stars, based on 1 article reviews
self-fluorescent dox-loaded hnps with unique aiegen characteristic - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
dox fluorescent dye  (Aktin Chemicals Inc)
90
Aktin Chemicals Inc dox fluorescent dye
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Dox Fluorescent Dye, supplied by Aktin Chemicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dox fluorescent dye/product/Aktin Chemicals Inc
Average 90 stars, based on 1 article reviews
dox fluorescent dye - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
doxycycline (dox)-inducible, polycistronic green fluorescence protein (gfp)-shrna expression constructs  (Transomic Technologies Inc)
90
Transomic Technologies Inc doxycycline (dox)-inducible, polycistronic green fluorescence protein (gfp)-shrna expression constructs
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Doxycycline (Dox) Inducible, Polycistronic Green Fluorescence Protein (Gfp) Shrna Expression Constructs, supplied by Transomic Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/doxycycline (dox)-inducible, polycistronic green fluorescence protein (gfp)-shrna expression constructs/product/Transomic Technologies Inc
Average 90 stars, based on 1 article reviews
doxycycline (dox)-inducible, polycistronic green fluorescence protein (gfp)-shrna expression constructs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
dox fluorescent marker  (Verlag GmbH)
90
Verlag GmbH dox fluorescent marker
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Dox Fluorescent Marker, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dox fluorescent marker/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
dox fluorescent marker - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
dox fluorescence intensity  (CEM Corporation)
90
CEM Corporation dox fluorescence intensity
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Dox Fluorescence Intensity, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dox fluorescence intensity/product/CEM Corporation
Average 90 stars, based on 1 article reviews
dox fluorescence intensity - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
fluorescent dye dox-loaded dna bs  (HORIBA Ltd)
90
HORIBA Ltd fluorescent dye dox-loaded dna bs
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Fluorescent Dye Dox Loaded Dna Bs, supplied by HORIBA Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent dye dox-loaded dna bs/product/HORIBA Ltd
Average 90 stars, based on 1 article reviews
fluorescent dye dox-loaded dna bs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
fluorescent dox metabolites  (CEM Corporation)
90
CEM Corporation fluorescent dox metabolites
Schematic diagram of <t>self-assembled</t> <t>TA6NT-AKTin-DOX.</t> TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.
Fluorescent Dox Metabolites, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent dox metabolites/product/CEM Corporation
Average 90 stars, based on 1 article reviews
fluorescent dox metabolites - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Schematic diagram of self-assembled TA6NT-AKTin-DOX. TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: Schematic diagram of self-assembled TA6NT-AKTin-DOX. TA6NT-AKTin-DOX consists of a CD44 aptamer TA6, DNA building blocks M1 and M2 conjugated by an AKT inhibitor peptide AKTin individually, and DOX. This aptamer-conjugated DNA nanotrain was first taken up via targeted endocytosis. Following the release in acidic organelles, DOX diffused into the cell nucleus and the AKTin inhibited AKT. Drug resistance reversal can be achieved by interfering ABCG2-mediated drug efflux and inducing apoptosis.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques:

Construction and characterization of TA6NT-AKTin-DOX. ( A ) Agarose gel electrophoresis showing the effect of TA6-tethered trigger concentration on HCR amplification. Lanes 1–5: five different concentrations of TA6-tethered trigger (0.00, 0.10, 0.20, 0.33 and 1.00 μM) in a 1 μM mixture of M1-AKTin and M2-AKTin. Lane 6: DL2000 DNA marker. ( B ) Fluorescence spectra of DOX (1 μM) with increasing equivalents of TA6NT-AKTin, at DOX/TA6NT-AKTin molar ratios of 320, 160, 80, 40, 20, 0 and DOX only, respectively. The fluorescence quenching indicates DOX loading into TA6NT-AKTin. ( C ) In vitro release profiles of DOX at pH 7.4 containing 10% FBS, pH 7.4, 5.0 and 5.0 with DNase II. Data are mean±SD (n=3). ( D ) Agarose gel electrophoresis of TA6NT-AKTin-DOX at pH 7.4 containing 10% FBS, pH 7.4, 5.0 and 5.0 with DNase II for 24 hrs. ( E ) Fluorescence images of BCSCs treated with both LysoTracker Green and TA6NT-AKTin-DOX.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: Construction and characterization of TA6NT-AKTin-DOX. ( A ) Agarose gel electrophoresis showing the effect of TA6-tethered trigger concentration on HCR amplification. Lanes 1–5: five different concentrations of TA6-tethered trigger (0.00, 0.10, 0.20, 0.33 and 1.00 μM) in a 1 μM mixture of M1-AKTin and M2-AKTin. Lane 6: DL2000 DNA marker. ( B ) Fluorescence spectra of DOX (1 μM) with increasing equivalents of TA6NT-AKTin, at DOX/TA6NT-AKTin molar ratios of 320, 160, 80, 40, 20, 0 and DOX only, respectively. The fluorescence quenching indicates DOX loading into TA6NT-AKTin. ( C ) In vitro release profiles of DOX at pH 7.4 containing 10% FBS, pH 7.4, 5.0 and 5.0 with DNase II. Data are mean±SD (n=3). ( D ) Agarose gel electrophoresis of TA6NT-AKTin-DOX at pH 7.4 containing 10% FBS, pH 7.4, 5.0 and 5.0 with DNase II for 24 hrs. ( E ) Fluorescence images of BCSCs treated with both LysoTracker Green and TA6NT-AKTin-DOX.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques: Agarose Gel Electrophoresis, Concentration Assay, Amplification, Marker, Fluorescence, In Vitro

( A ) Quantification of the ability to regenerate mammosphere of BCSCs after treating 2 µM DOX and TA6NT-AKTin-DOX for 12 hrs. ( B ) Cytotoxicity profiles of free DOX, TA6NT-DOX, TA6NT-AKTin together with DOX and TA6NT-AKTin-DOX for BCSCs (n=3). ( C ) Cellular apoptosis of BCSCs detected using TUNEL assay. Nuclei were stained with DAPI, and merged images were considered as apoptotic cells. ( D ) Fluorescence images of BCSCs and NIH-3T3 cells after the treatment of 2 µM free DOX, NT-AKTin-DOX and TA6NT-AKTin-DOX for 12 hrs, and ( E ) the measured DOX amounts in the whole cell and nucleus isolated from BCSCs (n=3). Two-tailed Student’s t -test was used. * p <0.05, ** p <0.01.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: ( A ) Quantification of the ability to regenerate mammosphere of BCSCs after treating 2 µM DOX and TA6NT-AKTin-DOX for 12 hrs. ( B ) Cytotoxicity profiles of free DOX, TA6NT-DOX, TA6NT-AKTin together with DOX and TA6NT-AKTin-DOX for BCSCs (n=3). ( C ) Cellular apoptosis of BCSCs detected using TUNEL assay. Nuclei were stained with DAPI, and merged images were considered as apoptotic cells. ( D ) Fluorescence images of BCSCs and NIH-3T3 cells after the treatment of 2 µM free DOX, NT-AKTin-DOX and TA6NT-AKTin-DOX for 12 hrs, and ( E ) the measured DOX amounts in the whole cell and nucleus isolated from BCSCs (n=3). Two-tailed Student’s t -test was used. * p <0.05, ** p <0.01.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques: TUNEL Assay, Staining, Fluorescence, Isolation, Two Tailed Test

Western blotting of p -AKT, AKT, ABCG2 and cleaved caspase-3 in BCSCs with the treatment of DOX and TA6NT-AKTin-DOX.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: Western blotting of p -AKT, AKT, ABCG2 and cleaved caspase-3 in BCSCs with the treatment of DOX and TA6NT-AKTin-DOX.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques: Western Blot

( A ) Tumor volume change, ( B ) tumor weight on day 25, ( C ) excised tumor and ( D ) body weight change of mice bearing BCSCs xenografts after the treatment of free DOX, TA6NT-DOX, TA6NT-AKTin together with DOX, TA6NT-AKTin-DOX and saline. * p <0.05, ** p <0.01. ( E ) The result of CBC testing.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: ( A ) Tumor volume change, ( B ) tumor weight on day 25, ( C ) excised tumor and ( D ) body weight change of mice bearing BCSCs xenografts after the treatment of free DOX, TA6NT-DOX, TA6NT-AKTin together with DOX, TA6NT-AKTin-DOX and saline. * p <0.05, ** p <0.01. ( E ) The result of CBC testing.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques: Saline

( A ) In vivo images of mice treated with 5 mg DOX equivalent/kg of free DOX, NT-AKTin-DOX and TA6NT-AKTin-DOX for 4 hrs. ( B ) The measured DOX amounts in tumors. Two-tailed Student’s t -test was used. * p <0.05, ** p <0.01.

Journal: International Journal of Nanomedicine

Article Title: Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin

doi: 10.2147/IJN.S200482

Figure Lengend Snippet: ( A ) In vivo images of mice treated with 5 mg DOX equivalent/kg of free DOX, NT-AKTin-DOX and TA6NT-AKTin-DOX for 4 hrs. ( B ) The measured DOX amounts in tumors. Two-tailed Student’s t -test was used. * p <0.05, ** p <0.01.

Article Snippet: The native fluorescence intensity of DOX decreased with increasing concentration of TA6NT-AKTin ( ).

Techniques: In Vivo, Two Tailed Test